What We Offer?
Successful development of a biopharmaceutical or biologic drug depends on ensuring
the
safety, efficacy, quality, purity, and potency of your
biopharmaceutical product. We support
comprehensive and biopharmaceutical analysis services tailored for research
and manufacturing.
Protein Characterization
In line with the ICH Q6B Guidance, Creative Proteomics offers protein analysis and characterization services including structure analysis, physicochemical properties, biological activity, immunochemical properties, and purity and impurities determination to ensure the quality and consistency of your product.
Learn More-
PEGylation Protein
PEGylation is a process of attaching one or more molecules of polyethylene glycol (PEG) to target biomolecules including peptides, proteins, and oligonucleotides. Scientists from Creative Proteomics are professional and experienced in PEGylation and provide efficient services that meet the requirements of FDA and ICH guidelines.
-
ADCs
We can provide services to test the physical, chemical and structural characteristics, purity, impurities, and contents of antibody-drug conjugates strictly following various quality standards.
-
Bispecific Antibodies
We use advanced high-performance liquid chromatography, mass spectrometry, and bioinformatics platforms to support the verification of each bsAb product.
-
F(ab) Fragment
We can comprehensively determine the primary structure, high-level structure, post-translational modification, and heterogeneity of F(ab) fragment.
-
Fusion Proteins
Our integrated biopharmaceutical characterization solution makes it possible to efficiently and accurately analyze fusion proteins for every study and ensure consistently reliable results, every time.
-
Vaccines
Our analytical scientists are highly experienced and knowledgeable in comprehensively characterizing vaccines.
Antibody Research
Creative Proteomics has extensive technical knowledge and long-standing experience in the detailed characterization of antibodies and antibody products.
Learn More
